{"id":"https://openalex.org/W3084841004","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4334.4334","title":"Apobec Family of Proteins Mediate Genomic Changes in Multiple Myeloma By Inducing DNA Damage and C>T Mutations","display_name":"Apobec Family of Proteins Mediate Genomic Changes in Multiple Myeloma By Inducing DNA Damage and C>T Mutations","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W3084841004","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4334.4334","mag":"3084841004"},"language":"en","primary_location":{"id":"mag:3084841004","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4334.4334","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/4334/72921/Apobec-Family-of-Proteins-Mediate-Genomic-Changes","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112389374","display_name":"Srikanth Talluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srikanth Talluri","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet Samur","raw_affiliation_strings":["Dana\u2010Farber Cancer Institute, Boston, MA;"],"raw_orcid":"https://orcid.org/0000-0002-9978-5682","affiliations":[{"raw_affiliation_string":"Dana\u2010Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036264384","display_name":"Leutz Buon","orcid":"https://orcid.org/0009-0000-5990-1936","observed_orcids":["https://orcid.org/0009-0000-5990-1936"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leutz Buon","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, BOSTON, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, BOSTON, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017577287","display_name":"Puru Nanjappa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Puru Nanjappa","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056254084","display_name":"RAO H. PRABHALA","orcid":"https://orcid.org/0000-0002-6375-0437","observed_orcids":["https://orcid.org/0000-0002-6375-0437"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rao Prabhala","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-6375-0437","affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-8932-6829","affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["J. Lipper Cancer Center for Multiple Myeloma, Dana Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-7344-9795","affiliations":[{"raw_affiliation_string":"J. Lipper Cancer Center for Multiple Myeloma, Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2111,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.62387775,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"130","issue":null,"first_page":"4334","last_page":"4334"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.823199987411499,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.823199987411499,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.1378999948501587,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/apobec-cytidine-deaminases","display_name":"APOBEC cytidine deaminases","score":0.9200000166893005},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.7540000081062317},{"id":"https://openalex.org/keywords/c-to-t-mutations","display_name":"C>T mutations","score":0.7870000004768372},{"id":"https://openalex.org/keywords/dna-double-strand-breaks","display_name":"DNA double-strand breaks","score":0.8690000176429749},{"id":"https://openalex.org/keywords/clonal-heterogeneity","display_name":"clonal heterogeneity","score":0.875},{"id":"https://openalex.org/keywords/apobec3b","display_name":"APOBEC3B","score":0.7620000243186951},{"id":"https://openalex.org/keywords/apobec3g","display_name":"APOBEC3G","score":0.9959999918937683},{"id":"https://openalex.org/keywords/apobec3a","display_name":"APOBEC3A","score":0.8220000267028809},{"id":"https://openalex.org/keywords/apobec3c","display_name":"APOBEC3C","score":0.9810000061988831},{"id":"https://openalex.org/keywords/dna-damage","display_name":"DNA damage","score":0.6140000224113464},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C2776162770","wikidata":"https://www.wikidata.org/wiki/Q4653351","display_name":"APOBEC","level":4,"score":0.9939294457435608},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.6821424961090088},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6184757947921753},{"id":"https://openalex.org/C128526571","wikidata":"https://www.wikidata.org/wiki/Q619302","display_name":"Somatic hypermutation","level":4,"score":0.6072597503662109},{"id":"https://openalex.org/C2776985229","wikidata":"https://www.wikidata.org/wiki/Q18021211","display_name":"Cytidine deaminase","level":3,"score":0.565291702747345},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.46315091848373413},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.445287823677063},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4419197142124176},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4284951686859131},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3688929080963135},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.3322109878063202},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.3191607594490051},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.28414851427078247},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.12392303347587585},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3084841004","doi":"https://doi.org/10.1182/blood.v130.suppl_1.4334.4334","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/4334/72921/Apobec-Family-of-Proteins-Mediate-Genomic-Changes","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2593489114","https://openalex.org/W3204759237","https://openalex.org/W2909261016","https://openalex.org/W2944771142","https://openalex.org/W2620427317","https://openalex.org/W2907838853","https://openalex.org/W2955262440","https://openalex.org/W2985664280","https://openalex.org/W2985199757","https://openalex.org/W4213236297"],"abstract_inverted_index":{"Abstract":[0],"Multiple":[3],"myeloma":[4,52,289],"(MM)":[5],"is":[6,53],"a":[7,33,64,153,388,473],"heterogeneous":[8],"disease":[9],"characterized":[10],"by":[11,245,260,266,384,490],"unstable":[12],"genome.":[13],"Spontaneous":[14],"DNA":[15,198,305,410,487,568],"damage":[16,411,569],"coupled":[17],"with":[18,80,111,127,284],"dysregulated":[19,394],"repair":[20,412,578],"accentuates":[21],"the":[22,43,67,106,205,273,296,303,326,340,348,415,469,486,496,531,590,595],"genomic":[23,49,399,499,554,597],"instability":[24,50,555],"seen":[25],"in":[26,36,51,58,73,81,115,125,150,171,191,196,215,225,237,240,253,288,317,325,339,345,395,414,421,431,458,463,468,509,556,583],"MM.":[27,116,151],"The":[28],"resulting":[29],"clonal":[30,113,135],"heterogeneity":[31],"plays":[32],"critical":[34],"role":[35,65,122],"resistance":[37],"to":[38,48,133,160,233,271,351,364,373,376,398,460,553,572,609],"treatment":[39,61],"and":[40,91,104,145,227,265,301,417,428,437,448,465,505,511,518,539,580],"relapse.":[41],"Understanding":[42],"molecular":[44],"factors":[45],"that":[46,96,140,187,355,381,480,526,545,565],"contribute":[47,571],"therefore":[54],"of":[55,70,87,99,123,189,207,209,220,276,314,320,342,347,357,366,371,378,390,454,498,528,533,548,575,592,594,607],"great":[56],"importance":[57],"developing":[59],"better":[60],"strategies.":[62],"Recently,":[63],"for":[66],"AID/APOBEC":[68],"family":[69],"cytidine":[71],"deaminases":[72],"generating":[74],"somatic":[75],"mutations":[76,100,322,362,540],"has":[77],"been":[78],"described":[79],"MM":[82,126,172,180,192,216,229,241,396,557],"as":[83,85,175,177,258,502],"well":[84,176],"number":[86,98,319,535],"other":[88],"cancers.":[89],"We":[90,117,138,202],"others":[92],"have":[93,118],"previously":[94],"shown":[95],"significant":[97],"bear":[101],"APOBEC":[102,107,124,157,169,210,246,250,285,334,406,435,442,455,491,512,566,586],"signature":[103,109],"interestingly,":[105],"mutation":[108],"correlates":[110],"sub":[112],"diversity":[114],"now":[119],"further":[120],"explored":[121],"special":[128],"focus":[129],"on":[130,212],"its":[131],"ability":[132],"induce":[134],"diversity.":[136],"observed":[139,166],"APOBECs":[141,190,221,315,358,529,549],"3A,":[142],"3B,":[143],"3C,":[144],"3G":[146,224],"are":[147,382],"highly":[148],"expressed":[149],"Using":[152,182,420],"fluorescent":[154],"oligonucleotide":[155],"based":[156],"deaminase":[158,162,238,247],"assay":[159],"measure":[161],"activity,":[163],"we":[164,185,279,294,402,425,478,494],"also":[165,337],"significantly":[167],"increased":[168,261,318,573],"activity":[170,239,407,423,430,450,467,587],"cell":[173,193,230,242],"lines":[174,194,231],"primary":[178],"patient":[179],"cells.":[181,217,290,332,419,439,558],"shRNA-mediated":[183],"knockdown,":[184],"report":[186],"depletion":[188,453],"results":[195,524,563],"decreased":[197],"double":[199,255],"strand":[200,256],"breaks.":[201],"next":[203],"investigated":[204,403,495],"impact":[206,275],"overexpression":[208,251,356,436],"genes":[211],"genome":[213,520,581],"integrity":[214],"Over":[218],"expression":[219,286,336,547],"3B":[222],"or":[223],"U266":[226],"LP1":[228],"led":[232],"3-5":[234],"fold":[235],"increase":[236],"extracts":[243,432],"measured":[244,426],"assay.":[248],"Furthermore,":[249,493],"resulted":[252,316,338,457],"elevated":[254,446,546],"breaks":[257,488],"evidenced":[259],"gH2AX":[262],"nuclear":[263],"foci":[264],"western":[267],"blot.":[268],"In":[269,560],"order":[270],"determine":[272],"functional":[274],"APOBEC-induced":[277],"mutations,":[278],"co-transfected":[280,329],"EGFP":[281,297,327],"plasmid":[282,304,328],"along":[283],"vectors":[287],"72-hrs":[291],"after":[292],"transfection,":[293],"isolated":[295,306],"plasmid,":[298],"transformed":[299],"bacteria,":[300],"sequenced":[302],"from":[307,310,434,441],"5":[308],"colonies":[309],"each":[311],"group.":[312],"Overexpression":[313],"C>T":[321],"(3-5":[323],"fold)":[324],"into":[330],"these":[331,576],"Interestingly,":[333,471],"over":[335,507,541],"loss":[341,365],"GFP":[343],"fluorescence":[344],"20-30%":[346],"cells":[349,444],"compared":[350],"control":[352,510],"cells,":[353,514],"suggesting":[354],"can":[359,484],"cause":[360],"deleterious":[361],"leading":[363],"function.":[367],"APOBEC-mediated":[369],"deamination":[370],"cytosine":[372],"uracil":[374],"leads":[375],"generation":[377],"abasic":[379,385],"sites":[380],"cleaved":[383],"endonuclease":[386],"(APE1),":[387],"regulator":[389],"homologous":[391],"recombination":[392],"pathway":[393,483],"contributing":[397,552],"instability.":[400],"Therefore,":[401],"how":[404],"modulating":[405],"affects":[408],"downstream":[409],"pathways":[413,579],"gain-of":[416],"loss-of-function":[418],"vitro":[422],"assays,":[424],"APE1":[427,447,466],"HR":[429,449,464,476,482],"collected":[433],"knockdown":[438,513,527],"Extracts":[440],"overexpressing":[443],"showed":[445],"(>50%),":[451],"whereas":[452],"proteins":[456],"up":[459],"80%":[461],"reduction":[462],"extracts.":[470],"using":[472,515],"small":[474],"molecule":[475],"inhibitor":[477],"found":[479],"inhibiting":[481],"reduce":[485,589],"induced":[489],"overexpression.":[492],"acquisition":[497],"changes":[500],"such":[501],"amplifications,":[503],"deletions,":[504],"SNVs":[506],"time,":[508],"SNP":[516],"arrays":[517],"whole":[519],"sequencing":[521],"(WGS).":[522],"Our":[523],"show":[525],"reduces":[530],"accumulation":[532,593],"copy":[534],"changes,":[536],"structural":[537],"variants":[538],"time.":[542],"This":[543],"suggests":[544],"may":[550],"be":[551],"summary,":[561],"our":[562],"suggest":[564],"mediated":[567],"could":[570,588],"dysregulation":[574],"important":[577],"stability":[582],"myeloma.":[584],"Inhibiting":[585],"rate":[591],"ongoing":[596],"changes.":[598],"Disclosures":[602],"No":[604],"relevant":[605],"conflicts":[606],"interest":[608],"declare.":[610]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-09-21T00:00:00"}